How to Accelerate Cures and Patient Outcomes Using RNA

View
Event Information

Event Topic:
How to Accelerate Cures and Patient Outcomes Using RNA

Event Description:
Personalized medicine relying on single biomarkers has been practiced for four decades, resulting in drug approvals with response rates of 20%-70% in cancers. Biomarkers that guide treatment decisions have been adopted in all indications, such as cancer, autoimmune, cardiovascular, and infectious diseases. However, less than 1/3 of all clinical programs use a biomarker, adding significant risk and cost to the study. Using just one biomarker can potentially reduce the cost of a study by up to $1B by reducing the trial size and timeline, thus de-risking the project. In addition, analyzing all RNAs enables truly individualized treatment. RNA-based algorithms have been implemented into the standard of care in cancer, cardiovascular diseases, and other diseases. However, RNA is much harder to analyze because the assay must be quantitative, and RNA is unstable in real clinical samples. Identifying and quantifying all RNAs enables the biomarker to become an algorithm while the assay remains the same, accelerating adoption.

Date/Time:
Date(s) - 02/28/23
8:30 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/88573518331:

Speaker Information

Event Speaker:
Gitte Pedersen

Event Speaker Title:
CEO & Co-Founder

Event Speaker Company:
Genomic Expression

Event Speaker Bio:
How to Accelerate Cures and Patient Outcomes Using RNA
Gitte is a scientist, company builder, and investor who aims to improve health and sustainability. She is an advisor to governments and has attracted +$2B of investments from big pharma and venture capitalists to several biotech companies in Denmark. In addition, Gitte is a board member of ESIR2, advising the European Commission on implementing evidence-based policies that drive sustainability. She is also an angel investor and limited partner in a fund that invests in companies that address United Nations sustainability goals. Gitte has participated in 5 start-up companies and is a co-founder of 3. She previously worked for Novo Nordisk and is a co-author on eight patents.

Event Details

Cost:
$0

Add To Calendar

0